Background: When determining the cause and severity of liver disease, a liver biopsy is still the gold standard. Experts in gastroenterology and hepatology or radiologists are the most common providers for percutaneous biopsies. The collection of liver tissue can be accomplished in several ways. Intravascular tissue sample through the hepatic vein, laparoscopy and laparotomy for intra-abdominal biopsy, and a blind percutaneous technique following percussion of the chest wall are all viable options. Availability, individual desire, and the needs of the patient inform which methods are used. Additionally, different needles might be used based on the treatment modality and the practitioner's level of expertise.Objective: Assessment of possible role of liver biopsy in evaluation of fibrosis. Methods: Liver biopsy, pediatrics, and fibrosis were all looked for in PubMed, Google scholar, and Science direct. References from relevant literature were also evaluated by the authors, but only the most recent or complete study from February 2013 to June 2021 was included. Due to the lack of sources for translation, documents in languages other than English have been ruled out. Papers that did not fall under the purview of major scientific investigations, such as unpublished manuscripts, oral presentations, conference abstracts, and dissertations, were omitted. Conclusion: Sampling mistake, uncommon complications, and occasional patient worry are possible outcomes of the typically safe procedure known as liver biopsy, which is now the gold standard for assessing hepatic inflammation and fibrosis.